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Background: Bronchiolitis is common in the first two years of life and is the most frequent cause of hospitalization
in this age group. No previous studies have used an episode-of-care analysis to describe the frequency, duration,
and predictors of bronchiolitis episodes of care during the first two years.
Methods: We conducted a retrospective cohort study of 123,264 infants ≥32 weeks gestation born at 6 Northern
California Kaiser Permanente hospitals between 1996 and 2002. We used electronic medical records to concatenate
hospital, emergency department and outpatient health care encounters for bronchiolitis into discrete episodes of
care. We used descriptive statistics to report frequency and duration of bronchiolitis episodes and used logistic
regression to assess the effect of gestational age and other clinical and demographic predictors on the outcome of
bronchiolitis episodes.
Results: Among all infants, the rate of bronchiolitis episodes was 162 per 1000 children during the first 2 years of
life; approximately 40% required >1 day of medical attention with a mean duration of 7.0 ± 5.9 days. Prematurity
was associated with increased risk of bronchiolitis episodes and longer duration. Bronchiolitis episodes rates per
1000 infants were 246 for 32–33 weeks gestational age, 204 for 34–36 weeks, and 148–178 for >36 weeks. Male
gender, African-American and Hispanic race/ethnicity, and parental history of asthma were associated with an
increased risk of having a bronchiolitis episode and/or longer duration.
Conclusions: Bronchiolitis episodes of care are frequent during the first two years of life and the duration ranges
from 1 to 27 days. Prematurity was associated with more frequent and longer duration of bronchiolitis episodes of
care, which may reflect illness severity and/or perceived vulnerability.Background
Bronchiolitis is the most common lower respiratory con-
dition in children younger than 2 years [1], and presents
with a wide spectrum of clinical illness, from mild symp-
toms to severe, life-threatening respiratory distress.
More severe bronchiolitis is the most frequent cause of
infant hospitalization in the United States [2,3] with
costs estimated at $543 million per year [4]. Bronchio-
litis also causes a substantial emergency department
(ED) and outpatient burden [5-7]. Populations at* Correspondence: FlahermanV@peds.ucsf.edu
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distribution, and reproduction in any mediumincreased risk for severe bronchiolitis include racial and
ethnic minorities and those who had preterm birth,
bronchopulmonary dysplasia (BPD) or congenital heart
disease. [6,8,9]
Previous research on the epidemiology of bronchiolitis
has focused on ascertaining rates of outpatient care, ED
visits, and hospitalizations, with widely differing results
that can be attributed to differences in study designs,
methodologies, and populations. Estimates of the rate of
outpatient visits for children <2 years range from 103
per 1000 children [2] to 238 visits per 1000 child years
[5]. Estimates of the rate of hospitalization also vary.
Koehoorn et al. [10] found a hospitalization rate of 17.1
per 1000 child years for children <1 year. Shay et al.,tral Ltd. This is an Open Access article distributed under the terms of the
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infants <1 year ranging from 12.9 per 1000 in 1980 to
31.2 per 1000 in 1996 [11], whereas Carroll et al. [5]
estimated a higher rate of 71 per 1000 child years during
1995–2003. Carroll et al. [5] also estimated a rate of 77
ED visits per 1000 child years. Respiratory syncytial virus
is an important cause of bronchiolits, and recent re-
search has examined the prevalence of respiratory syn-
cytial virus (RSV) among children presenting for
medical care, and found that 15-20% of children present-
ing for care had RSV infection or co-infection [12].
These existing studies have tabulated the frequency of
hospitalizations and individual outpatient visits for bron-
chiolitis, and have estimated the frequency of RSV infec-
tion among those receiving care, but have not provided a
comprehensive description of the healthcare utilization
for each infant over a specific time period. In order to
provide such a comprehensive description, health care ef-
fectiveness researchers have promoted “episode of care”
analysis. Hornbrook et al. [13] first defined an episode as
a “series of temporally contiguous health services related
to treatment of a given spell of illness or provided in re-
sponse to a specific request by the patient.” Recently epi-
sode analysis has been used as an important tool for
estimating costs, determining patterns of use, evaluating
outcomes of care, and understanding medical practice
variation [13-15], using the entire duration of care as the
basis for measurement, with the assumption that this will
be more effective than counting single outpatient visits
or single hospitalizations [13,14,16]. To the best of our
knowledge, no previous studies have defined episodes of
care for bronchiolitis or have reported their frequency,
duration or risk during the first 2 years of life.
In this study, we use an “episodes of care” (henceforth,
“episode” or EOC) approach to determine the frequency,
duration and risk factors for bronchiolitis in children
<2 years among members of a large, integrated health-
care system in Northern California. Using this approach,
we analyze our results by gestational age (GA) to exam-
ine the burden of disease among those born preterm,
who are considered at high risk for bronchiolitis [17].
Below we describe the frequency, duration and charac-
teristics of bronchiolitis episodes and the clinical and
demographic predictors of bronchiolitis episodes longer
than one day among preterm and term infants.
Methods
Study design
This study was approved by the Kaiser Permanente
Medical Care Program (KPMCP) Institutional Review
Board for the Protection of Human Subjects, which has
jurisdiction over all the hospitals and clinics described in
this study. We conducted a retrospective cohort study
that included infants ≥32 weeks GA born and dischargedalive from one of 6 Northern California KPMCP hospi-
tals between 1996 and 2004. Infants <32 weeks GA at
birth represent a large portion of all infants who receive
RSV prophylaxis in our integrated healthcare system and
represent only a small portion of all preterm infants
born annually [18]. Consequently, infants <32 weeks
GA were not included in this study due to routine ad-
ministration of RSV immunoprophylaxis. To reduce the
effects of loss to follow up on our analysis we identified
those infants who remained KPMCP members until they
were two years of age. We included subjects in the co-
hort if they were members for ≥20 of the 24 months
after the infant’s birth, and if they had no more than two
consecutive months without membership. Subjects were
defined as members for each month in the study if they
were either insured by KPMCP or used KPMCP medical
services. See Figure 1 for flowchart of the cohort
selection.
We extracted data regarding these infants from
KPMCP databases, including inpatient and outpatient
encounters and diagnoses. Because there may be some
use of KPMCP facilities without membership, we con-
ducted a sensitivity analysis examining our results
among a subcohort of infants who were recorded as
members for all 24 months after the infant’s birth (see
Additional file 1: Tables S1, S2, and S3). The race/ethni-
city of participants was based on the self-reported race/
ethnicity of infants' mothers.
Variables and measurements
To identify only episodes that included a true diagnosis
of bronchiolitis while capturing all relevant clinical in-
formation associated with a bronchiolitis episode, we
classified relevant International Classification of Diseases
(ICD-9) codes into two categories. Category A included
diagnostic codes specific for bronchiolitis in children
younger than two years (ie, 466.1 acute bronchiolitis,
466.1x acute bronchiolitis organism specified, 466.0
acute bronchitis, 480.0–480.2 pneumonia due to adeno-
virus, RSV or parainfluenza, 079.0 adenovirus and 079.6
RSV). Category B included diagnostic codes likely to be
highly related to bronchiolitis in a child with a current
diagnosis of bronchiolitis (i.e., 786.06 tachypnea, 786.07
wheezing, 786.09 other respiratory distress, 780.6–
780.60, 786.2 cough, 460 acute nasopharyngitis, 465
acute upper respiratory infections, 465.9 acute upper re-
spiratory infection not otherwise specified, and 487.1
acute upper respiratory infection due to influenza.)
We defined a bronchiolitis episode as a period that
included a diagnostic code specific for bronchiolitis from
Category A, began either with the first bronchiolitis-
related diagnostic code from Category B occurring
within 2 days prior to the first Category A code or with
the first Category A code if there was no Category B
Figure 1 Cohort Selection Process.
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and ended with a diagnostic code from either Category
A or Category B followed by 14 clear days without a
bronchiolitis or related diagnosis. An episode of care can
include multiple healthcare visits and/or various types of
healthcare visits, including hospitalization or outpatient
visits with the aforementioned category codes. The dur-
ation of an episode of care is defined as the length of
time between the first and last visit.
For all infants, we extracted data regarding additional
clinical predictors including GA, sex, race/ethnicity, ma-
ternal age, birth weight, a diagnosis of BPD or congenital
anomaly (ICD-9 codes 425.3x, 425.4x, 425.8x, 745.xx,
746.xx, 747.xx) and the number of siblings present in
the home (≥1 sibling <5 years of age). For
hospitalization records, we also determined whether the
infant required assisted ventilation (ICD-9 codes 93.90,
93.91, and 96.7x).
We classified infants as being small for gestational age
(SGA) (<5th percentile) using birth weight and GA
according to the algorithm developed by Brenner et al.
[19]. We fitted a smooth cubic spline as a function of total
oxygen exposure separately for births occurring at 32–37
and ≥37 weeks GA. Both curves showed a flat effect for
total oxygen exposure <200 hours and a clear increase at
>200 hours, suggesting a step function and no interaction
between GA and total length of oxygen therapy. For
infants treated in the neonatal intensive care unit, we cre-
ated an oxygen exposure variable: no supplemental oxygen
exposure during the neonatal period, no bronchopulmon-
ary dysplasia (BPD); supplemental oxygen exposure of 1
to <200 hours during the neonatal period, no BPD; sup-
plemental exposure ≥200 hours during the neonatal
period, no BPD; and BPD. We classified infants who did
not require intensive care during the neonatal period as
having no supplemental oxygen exposure.
Parental asthma history was established by scanning
the parent’s records for the period 18 months before to
6 months after the infant’s birth and determiningwhether the parent had ≥2 clinical visits 14 days apart
with an ICD-9 code (493.xx) for asthma, and/or the par-
ent’s electronic record listed asthma on their Significant
Problem List.
Statistical analysis
All statistical analyses used SAS (version 9.1, SAS Insti-
tute, Inc., Cary, NC) or Stata (version 9.2, Stata Corp.,
College Station, TX). After identifying duration of epi-
sode, we eliminated episodes lasting >60 days from fur-
ther analysis because it was unlikely that these
represented isolated bronchiolitis (see Additional file 1:
Table S4). Manual chart review of infants with episodes
lasting >60 days confirmed that these episodes repre-
sented hospitalizations for which bronchiolitis was not
the primary diagnosis. Infants remaining after this step
constituted the final analysis cohort. We used descriptive
statistics to report frequency and duration of bronchio-
litis episodes and frequency of hospitalization associated
with the episode, by age at the episode, gender, GA, and
race/ethnicity. We used a moving average of GA and
GA minus 1 week to develop a graph of mean, 10th per-
centile and 90th percentile for the duration of EOC for
each GA. We used multivariable logistic regression to
assess the effect of GA, gender, race/ethnicity, family
history of asthma, neonatal oxygen use and other clinical
predictors on the outcome of whether an infant had a
documented bronchiolitis EOC and on the outcome of
whether an infant had a documented bronchiolitis EOC
lasting >1 day. We used White race/ethnicity as the
referent category for this multivariate analysis because
this was the largest population in our cohort and be-
cause previous literature has described disparate risk of
bronchiolitis for non-White racial/ethnic groups. We
calculated the relative contribution of each predictor
using the differences between the log likelihood of the
full model and the log likelihood of a model without
each of the predictors, and the relative contribution of
each predictor was defined as the ratio of its log
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ences from all predictors × 100 [20].Results
We selected our cohort from 165,089 surviving births
during 1996 to 2004 at the six Northern California
KPMCP hospitals equipped with neonatal intensive care
units. From this original birth population we removed 81
infants with missing information, 2,393 infants born
<32 weeks GA, 39,340 infants who did not meet prede-
fined membership criteria, and an additional 11 infants
with episode duration >60 days, resulting in a finalTable 1 Demographic and clinical characteristics of the main
All infants, n (%)













Small for gestational ageb 1,763 (1.4)
Congenital anomaly presentc 8,646 (7.0)
Family history of asthmad
None 116,763 (94.7)
Father only 1,824 (1.5)
Mother only 4,561 (3.7)
Both parents 116 (0.1)
≥1 sibling <5 y of age in home 44,235 (35.9)
O2 exposure and BPD
e
No O2 exposure, no BPD 118,599 (96.2)
<200 hr O2, no BPD 4,117 (3.3)
≥200 hr O2, no BPD 466 (0.4)
BPDf 82 (0.1)
BPD = bronchopulmonary dysplasia.
aClassification of race/ethnicity in this study was based on the race of infants' moth
Kaiser Permanente hospitals described in this study. Race was assessed in this stud
bBased on the algorithm of Brenner WE, et al. [19].
cSee text for list of included International Classification of Diseases codes.
dAscertained by electronic scanning of parental records, which included encounters
physician.
eOxygen exposure, in hours, during the birth hospitalization. See text for details.
fAll infants with BPD had ≥200 hours of oxygen exposure during the neonatal periocohort of 123,264 infants. The demographics and clinical
characteristics of the cohort are presented in Table 1.
Our main analysis focused on bronchiolitis episodes,
which included ≥1 medically attended visit for bronchio-
litis. Among all infants (123,264), 19,968 infants devel-
oped ≥1 episode for bronchiolitis during their first
two years of life. Overall, there were 23,748 episodes
identified throughout the study period. Among infants
who experienced an episode, the mean number of epi-
sodes per infant was 1.2 within the first two years of life,
so that 16.2% of infants eventually developed bronchio-
lits. The overall mean (± SD) duration of episodes was
3.2 ± 4.7 days. Overall, 2,036 (8.6%) episodes included acohort and subgroups
Infants with any
bronchiolitis episode
before age 2 y, n (%)
Infants with any bronchiolitis
episode before age 2 y
lasting >1 d, n (%)
11,730 (58.7) 5,206 (60.1)
8,305 (41.6) 3,754 (43.4)
1,866 (9.3) 740 (8.6)
3,599 (18.0) 1,505 (17.4)
4,704 (23.6) 2,047 (23.6)
1,494 (7.5) 612 (7.1)
406 (2.0) 218 (2.5)
1,622 (8.1) 830 (9.6)
1,400 (7.0) 632 (7.3)
13,701 (68.6) 5,834 (67.4)
2,839 (14.2) 1,144 (13.2)
323 (1.6) 168 (1.9)
1,642 (8.2) 764 (8.8)
18,618 (93.2) 8,011 (92.5)
336 (1.7) 160 (1.9)
989 (5.0) 476 (5.5)
25 (0.1) 11 (0.1)
8,405 (42.1) 3,801 (43.9)
18,941 (94.9) 8,126 (93.9)
867 (4.3) 427 (4.9)
138 (0.7) 89 (1.0)
22 (0.1) 16 (0.2)
ers, as self-reported to the birth certificate clerk interviewing them at the
y because of the well-known differences in RSV severity by race.
and diagnoses identified in the Significant Problem List by the parent’s
d.
Table 2 Episode frequency and duration and associated hospitalization during the first two years of life
Gestational
age, wk
Infants, n Infants with
at least one
EOC, n
Rate of at least
one episode per
thousand children
EOCa, n Mean episode
duration, d (SD)
Episode consisting of ED
visit and hospitalization
and lasting >1 db, n (%)
Episode with any
hospitalization, n (%)
32–33 1,649 406 246.2 523 4.4 (5.5) 37 (14.2) 101 (19.3)
34–36 7,969 1,622 203.5 2,003 3.9 (5.0) 72 (7.8) 254 (12.7)
37 7,855 1,400 178.2 1,681 3.4 (4.6) 44 (6.4) 151 (9.0)
38–40 86,708 13,701 158.0 16,172 3.3 (4.7) 396 (6.3) 1,288 (8.0)
≥41 19,083 2,839 148.8 3,369 3.2 (4.7) 70 (5.6) 242 (7.2)
Total 123,264 19,968 162.0 23,748 3.2 (4.7) 619 (6.6) 2,036 (8.6)
ED = emergency department. EOC = Episode of Care.
aAcross episodes during the first two years of life, there were a total of 35,703 outpatient visits for a rate of 289 per 1000 children, a total of 1909 emergency
department visits for a rate of 15 per 1000 children and 2169 hospitalizations for a rate of 17.5 per 1000 children.
bDenominator is among episodes >1 day for each gestational age cohort.
Figure 2 Bronchiolitis episode of care duration as a function of
gestational age.
Flaherman et al. BMC Health Services Research 2012, 12:144 Page 5 of 8
http://www.biomedcentral.com/1472-6963/12/144hospitalization. Of note, 6,351 (26.7%) included a diag-
nosis of otitis media.
Among episodes lasting >1 day (40%), the mean dur-
ation was 7.0 ± 5.9 days; of all episodes, 13.4% lasted 2–
3 days, 11.3% lasted 4–6 days, 10.0% lasted 7–13 days
and 5.0% lasted ≥14 days. The mean number of out-
patient visits among episodes lasting >1 day was 2.3,
while the mean number of emergency department (ED)
visits was 0.2. The majority (85.2%) of episodes with an
ED visit for bronchiolitis had no other healthcare
encounters during the episode. However, among children
who had an ED visit for bronchiolitis, the mean episode
length was 6.3 days and the proportion of infants admit-
ted to the hospital was 35.6% (n = 626).
Preterm birth was associated with both frequency
and duration of bronchiolitis episodes (Table 2). The
episode rate and corresponding mean duration
increased with lower GA. The rate during the first
two years of life and mean duration of bronchiolitis EOC
were 246 per 1000 infants and 4.4 ± 5.5 days, respectively,
for infants born at 32–33 weeks and 204 per 1000 infants
and 3.9 ± 5.0 days, respectively, for infants born at
34–36 weeks GA. In contrast, the rate of episodes among
full term infants was lower, 149–178 per 1000 infants.
Infants of 32–33 weeks gestational age were also twice as
likely as term infants to have a bronchiolitis episode that
included an ED visit and a hospitalization (14.2% vs.
6.4%). Figure 2 shows the increased trend in duration of
bronchiolitis episodes in infants with lower GA. We
also examined episodes by chronologic age. Overall,
10,380 (43.7%) episodes occurred in infants <6 months
of age. For infants <6 months of age, the proportion
of bronchiolitis episodes including a hospitalization
was 11.5%; this proportion was 6% for those aged
6–24 months.
In our multivariable model, demographic characteris-
tics of male gender and African-American and Hispanic
race/ethnicity were associated with increased risk of any
episode with odds ratios (OR) of 1.44 (95% CI, 1.39–1.48), 1.19 (95% CI, 1.12–1.25) and 1.20 (95% CI, 1.15–
1.25), respectively, while adjusting for confounding vari-
ables (Table 3). In the same model, Asian race/ethnicity
and maternal age ≥35 years were associated with
decreased risk of a bronchiolitis episode with OR of 0.91
(95% CI, 0.87–0.95) and 0.90 (95% CI, 0.86–0.93), re-
spectively. Gestational age was an important predictor of
any bronchiolitis episode, with infants at 32–33 weeks
GA having an OR of 1.57 (95% CI, 1.39–1.77), infants
34–36 weeks GA having an OR of 1.32 (95% CI, 1.24–
1.40), infants at 37 weeks GA having an OR of 1.15 (95%
CI, 1.08–1.22), and infants ≥41 weeks GA having an OR
of 0.95 (95% CI, 0.90–0.99) for the outcome of any epi-
sode when compared with infants 38–40 weeks GA.
Other significant risk factors for bronchiolitis episodes
included small for GA, presence of congenital anomaly,
family history of asthma, at least one sibling <5 years of
age in the home, and degree of oxygen exposure or hav-
ing BPD.
The relative contribution of predictors to the overall
predictive ability of our model was as follows: gender
accounted for 36.0%, while presence of a sibling <5 years
Table 3 Effect of demographic and clinical predictors on
eventual bronchiolitis episodes in multivariate analysis
Clinical and demographic predictors Beta Odds Ratio (95% CI)
Sex (Male) 0.36 1.44 (1.39–1.48)
Racea
White 1.00 reference
African-American 0.17 1.19 (1.12–1.25)
Asian −0.10 0.91 (0.87–0.95)
Hispanic 0.18 1.20 (1.15–1.25)
Other/unknown −0.01 0.99 (0.93–1.05)
Gestational age, wk
32–33 0.45 1.57 (1.39–1.77)
34–36 0.27 1.32 (1.24–1.40)
37 0.14 1.15 (1.08–1.22)
38–40 1.00 reference
≥41 −0.06 0.95 (0.90–0.99)
Small for gestational ageb 0.16 1.17 (1.03–1.32)
Congenital anomaly presentc 0.13 1.14 (1.08–1.21)
Family history of asthmad
None 1.00
Father only 0.16 1.17 (1.04–1.32)
Mother only 0.37 1.45 (1.35–1.56)
Both parents 0.38 1.46 (0.94–2.29)
≥1 sibling <5 y of age in home 0.33 1.39 (1.35–1.44)
O2 exposure and BPD
e
No O2 exposure, no BPD 1.00 reference
<200 hr O2, no BPD 0.17 1.19 (1.10–1.29)
≥200 hr O2, no BPD 0.58 1.79 (1.46–2.20)
BPDf 0.28 1.33 (0.80–2.19)
Maternal age, y
<18 0.09 1.10 (0.96–1.25)
18–34 1.00 reference
≥35 −0.11 0.90 (0.86–0.93)
BPD = bronchopulmonary dysplasia.
aClassification of race/ethnicity in this study was based on the race of infants'
mothers, as self-reported to the birth certificate clerk interviewing them at the
Kaiser Permanente hospitals described in this study. Race was assessed in this
study because of the well-known differences in RSV severity by race.
bBased on the algorithm of Brenner WE, et al. [19].
cSee text for list of included International Classification of Diseases codes.
dAscertained by electronic scanning of parental records, which included
encounters and diagnoses identified in the Significant Problem List by the
parent’s physician.
eOxygen exposure, in hours, during the birth hospitalization. See text for
details.
fAll infants with BPD had ≥200 hours of oxygen exposure during the neonatal
period.
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11.3%, and GA accounted for 10.1%. The contribution of
other predictors was <7% each (see Additional file 1:
Table S5). In multivariable analyses, predictors for hav-
ing any episode were similar to predictors for having an
episode lasting> 1 day (Table 4; see also Additional file
1: Table S5). Results for both multivariate models weresimilar for the sensitivity analysis cohort (see Additional
file 1: Table S2 and Additional file 1: Table S3).
Discussion
Our study shows that bronchiolitis care episodes were
frequent during the first two years of life in this study co-
hort and that, consistent with prior research, most oc-
curred outside the hospital setting. In our large cohort,
the duration of bronchiolitis episodes ranged from 1 to
27 days. Among episodes with duration >1 day, the
mean duration was 7.0 ± 5.9 days, potentially indicating
significant morbidity for this subset of infants. Preterm
infants compared to full-term infants had higher overall
bronchiolitis episode rates as well as higher rates of epi-
sodes with an ED and/or inpatient hospital admission
during the first two years of life, which might reflect both
an intrinsically higher risk of morbidity in this population
and/or an increased level of parent and provider concern
regarding their medical needs. In addition to prematurity,
male gender, neonatal oxygen use, family history of
asthma, and African-American or Hispanic race/ethnicity
were associated with a higher frequency of at least one
episode and/or a higher frequency of an episode >1 day.
Consistent with previous studies, the overall burden of
disease in this population was relatively high, with 16.2%
of children in this study having a documented episode of
bronchiolitis before age two. An episode of care ap-
proach in characterizing the utilization patterns of
infants and children with bronchiolitis may be useful for
health services researchers, physicians, and parents in
understanding a broader healthcare burden of disease.
Analyzing episodes of care may be more informative
than reporting the rates of discrete bronchiolitis-related
medical encounters.
Our study has several important limitations. First, not
all infants with bronchiolitis seek medical care. This
study reports frequency and associated characteristics of
bronchiolitis that led to a clinical encounter, but is not a
prospective study of the entire burden of illness from
bronchiolitis that includes patient reports of symptoms
[21]. Nevertheless, the study design provided a good ap-
proximation of the total health care utilization associated
with bronchiolitis. Second, we ascertained bronchiolitis
diagnoses using ICD-9 codes. To be considered an epi-
sode, a subject needed to have ≥1 diagnostic code specific
for bronchiolitis or viral pneumonia attributable to
pathogens typically causing bronchiolitis (Category A).
Because bronchiolitis is a clinical diagnosis, it is possible
that some cases of bronchiolitis were instead coded as
“fever,” “wheeze,” or “lower respiratory infection.”How-
ever, it is also possible that some pneumonia attributed
to pathogens typically causing bronchiolitis was not in
fact bronchiolitis, and that some episodes of asthma, viral
pneumonia or upper respiratory infection were coded as
Table 4 Effect of demographic and clinical predictors on
eventual bronchiolitis episodes >1 day in multivariate
analysis
Clinical and demographic predictors Beta Odds Ratio (95% CI)
Sex (Male) 0.38 1.47 (1.40–1.54)
Racea
White 1.00 reference
African-American 0.01 1.01 (0.93–1.10)
Asian −0.17 0.85 (0.79–0.90)
Hispanic 0.13 1.13 (1.07–1.20)
Other/unknown −0.11 0.89 (0.82–0.98)
Gestational age, wk
32–33 0.58 1.79 (1.53–2.09)
34–36 0.43 1.53 (1.41–1.66)
37 0.18 1.20 (1.10–1.31)
38–40 1.00 reference
≥41 −0.11 0.90 (0.84–0.96)
Small for gestational ageb 0.32 1.37 (1.16–1.61)
Congenital anomaly presentc 0.15 1.17 (1.08–1.27)
Family history of asthmad
None 1.00 reference
Father only 0.24 1.27 (1.08–1.50)
Mother only 0.45 1.56 (1.41–1.72)
≥1 sibling <5 y of age in home 0.37 1.45 (1.39–1.52)
O2 exposure and BPD
e
No O2 exposure, no BPD 1.00 reference
<200 hr O2, no BPD 0.22 1.25 (1.12–1.39)
≥200 hr O2, no BPD 0.88 2.41 (1.89–3.07)
BPDf 0.69 1.99 (1.13–3.49)
Maternal age, y
<18 0.03 1.03 (0.85–1.26)
18–34 1.00 reference
≥35 −0.09 0.91 (0.86–0.96)
BPD = bronchopulmonary dysplasia.
aClassification of race/ethnicity in this study was based on the race of infants'
mothers, as self-reported to the birth certificate clerk interviewing them at the
Kaiser Permanente hospitals described in this study. Race was assessed in this
study because of the well-known differences in RSV severity by race.
bBased on the algorithm of Brenner WE, et al. [19].
cSee text for list of included International Classification of Diseases codes.
dAscertained by electronic scanning of parental records, which included
encounters and diagnoses identified in the Significant Problem List by the
parent’s physician.
eOxygen exposure, in hours, during the birth hospitalization. See text for
details.
fAll infants with BPD had ≥200 hours of oxygen exposure during the neonatal
period.
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from miscoding of bronchiolitis is relatively small. Third,
we estimated membership based on a combination of
membership and use status in each cohort month. Be-
cause infants with a higher level of use might tend to
have higher frequency of seeking medical care, it is pos-
sible that this might bias the results towards higherestimates of bronchiolitis episodes. Since the sensitivity
analysis including only infants with 24 months of docu-
mented membership did not show much difference from
the primary analysis, the effect of membership status is
likely to be minimal. Fourth, there were no reliable data
on smoking for this analysis. Because smoking in the
home is a major predictor of bronchiolitis episodes and
because maternal smoking is associated with preterm
birth and with race/ethnicity, it is possible that smoking
might confound the relationship between GA and inci-
dence of bronchiolitis. However, in our previous work we
have found that the overall rate of smoking among
mothers delivering at KPMCP is 4%–8% [22]. Therefore,
we do not believe this has had a large impact on our
results. Fifth, because rates of episodes and episodes with
hospitalization might be impacted by participation in an
integrated healthcare delivery system, it is possible that
our results may not be generalizable to other healthcare
systems. However, because the KPMCP provides medical
care to a large portion of infants born in Northern Cali-
fornia, our data represent an important estimate of over-
all care episodes in this population. Sixth, our data on
race/ethnicity include only the categories White, Afri-
can-American, Asian, Hispanic and other, and we do not
have access to more detailed data. Therefore, we cannot
report how more specific subgroups of race/ethnicity
might alter bronchiolitis risk.
Despite these limitations, our research design offers
the unique opportunity to study an entire birth cohort
using linked data with relatively little loss to follow-up
and to report the health care utilization related to bron-
chiolitis in this prospective cohort. Thus, we are able to
provide a comprehensive description of burden of dis-
ease in this population, including frequency and severity
of illness. In addition, the large sample size of our cohort
has allowed us to identify many predictors associated
with the disease outcome, which include gestational age,
race/ethnicity, maternal age, small for GA, presence of
congenital anomaly, family history of asthma, at least
one sibling <5 years of age in the home, and degree of
oxygen exposure or having BPD.Conclusions
In this cohort, 16.2% of infants had one or more epi-
sodes of bronchiolitis in the first two years after birth,
with episodes lasting from 1 to 27 days. Preterm infants
were more likely to have a bronchiolitis episode com-
pared to term infants and were more likely than term
infants to have longer periods of healthcare utilization,
perhaps reflecting both the medical needs of this par-
ticular high-risk population group and the vulnerability
perceived by providers and parents. Using an episode of
care approach to study the epidemiology of bronchiolitis
Flaherman et al. BMC Health Services Research 2012, 12:144 Page 8 of 8
http://www.biomedcentral.com/1472-6963/12/144may provide additional information about burden of dis-
ease for both preterm and term infants.
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